Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16.

Wu Z, Gao Y, Sun L, Tien P, Jin Q.

Antiviral Res. 2008 Dec;80(3):295-301. doi: 10.1016/j.antiviral.2008.06.017. Epub 2008 Jul 26.

PMID:
18662724
2.

[RNA interference and its application in inhibiting HIV-1 infection].

Wei L, Liu X, Cao C.

Sheng Wu Gong Cheng Xue Bao. 2005 Jul;21(4):516-9. Review. Chinese.

PMID:
16176084
3.

RNA interference and its therapeutic potential against HIV infection.

Singh SK.

Expert Opin Biol Ther. 2008 Apr;8(4):449-61. doi: 10.1517/14712598.8.4.449 . Review.

PMID:
18352849
4.

Therapeutic application of RNA interference for hepatitis C virus.

Watanabe T, Umehara T, Kohara M.

Adv Drug Deliv Rev. 2007 Oct 10;59(12):1263-76. Epub 2007 Aug 11. Review.

PMID:
17822803
5.

Management of chronic hepatitis B virus infection: a promising approach using small interfering RNA (siRNA).

Dwivedi M, Misra SP, Misra V, Waikhom RK, Bhatnagar M.

Natl Med J India. 2008 May-Jun;21(3):123-7. Review.

PMID:
19004143
6.

Potential role of RNAi in the treatment of HCV infection.

Volarevic M, Smolic R, Wu CH, Wu GY.

Expert Rev Anti Infect Ther. 2007 Oct;5(5):823-31. Review.

PMID:
17914916
7.

Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.

Takahashi Y, Nishikawa M, Takakura Y.

Adv Drug Deliv Rev. 2009 Jul 25;61(9):760-6. doi: 10.1016/j.addr.2009.04.006. Epub 2009 Apr 20. Review.

PMID:
19386274
8.

RNA interference and HIV-1 infection.

Kanzaki LI, Ornelas SS, ArgaƱaraz ER.

Rev Med Virol. 2008 Jan-Feb;18(1):5-18. Review.

PMID:
17764099
9.

RNA interference against retroviruses.

Hu WY, Bushman FD, Siva AC.

Virus Res. 2004 Jun 1;102(1):59-64. Review.

PMID:
15068881
10.

Does RNA interference have a future as a treatment for HIV-1 induced disease?

Cullen BR.

AIDS Rev. 2005 Jan-Mar;7(1):22-5. Review.

PMID:
15875658
11.

Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.

Reischl D, Zimmer A.

Nanomedicine. 2009 Mar;5(1):8-20. doi: 10.1016/j.nano.2008.06.001. Epub 2008 Jul 18. Review.

PMID:
18640078
12.

Inhalable siRNA: potential as a therapeutic agent in the lungs.

Durcan N, Murphy C, Cryan SA.

Mol Pharm. 2008 Jul-Aug;5(4):559-66. doi: 10.1021/mp070048k. Epub 2008 May 21. Review.

PMID:
18491918
13.

Small RNAs and the control of transposons and viruses in Drosophila.

van Rij RP, Berezikov E.

Trends Microbiol. 2009 Apr;17(4):163-71. doi: 10.1016/j.tim.2009.01.003. Epub 2009 Mar 18. Review.

PMID:
19299135
14.

RNAi therapeutics: an update on delivery.

Nguyen T, Menocal EM, Harborth J, Fruehauf JH.

Curr Opin Mol Ther. 2008 Apr;10(2):158-67. Review.

PMID:
18386228
15.

Solid-phase synthesis of siRNA oligonucleotides.

Beaucage SL.

Curr Opin Drug Discov Devel. 2008 Mar;11(2):203-16. Review.

PMID:
18283608
16.

Progress towards therapeutic application of RNA interference for HIV infection.

Singh SK, Gaur RK.

BioDrugs. 2009;23(5):269-76. doi: 10.2165/11317120-000000000-00000. Review.

PMID:
19754217

Supplemental Content

Support Center